ATGE

Adtalem Global Education Inc

Add to Watchlist

Advanced Chart

115.120

+0.82(0.717%)1D

Overview
Forecast
Valuation
Earnings

Line

Candle

YTD

High

116.5479

Open

114.810

VWAP

115.19

Vol

304.84K

Mkt Cap

4.14B

Low

113.750

Amount

35.11M

EV/EBITDA(TTM)

11.28

Total Shares

37.61M

4.47B

EV/OCF(TTM)

14.17

P/S(TTM)

2.55

Adtalem Global Education Inc. is a provider of healthcare education in the United States, preparing a diverse workforce with academic programs. Its healthcare programs include nursing, medicine, veterinary medicine, social and behavioral sciences and more. Its segments include Chamberlain, Walden, and Medical and Veterinary. Chamberlain segment offers degree and certificate programs in the nursing and health professions postsecondary education industry. Walden segment offers degree and certificate programs, including those in nursing, education, counseling, business, psychology, public health, social work and human services, public administration and public policy, and criminal justice. Medical and Veterinary segment offers degree and certificate programs in the medical and veterinary postsecondary education industry. This segment includes American University of the Caribbean School of Medicine, Ross University School of Medicine, and Ross University School of Veterinary Medicine.

Market Estimates

Earnings Estimates

Revenue

YoY Chg

EPS

YoYChg

FY2026Q2

FY2026Q1

FY2025Q4

477.32M

+6.61%

2.045

+12.98%

442.42M

+5.99%

1.490

+15.5%

440.93M

+7.57%

1.532

+11.86%

Estimates Revision

The market is revising Upward the revenue expectations for Adtalem Global Education Inc. (ATGE) for FY2025, with the revenue forecasts being adjusted by 1.16% over the past three months. During the same period, the stock price has changed by 8.14%.

Revenue Estimates for FY2025

Revise Upward

+1.16%

In Past 3 Month

EPS Estimates for FY2025

Revise Upward

+2.95%

In Past 3 Month

Stock Price

Go Up

+8.14%

In Past 3 Month

3 Analyst Rating

20.16% Upside

Wall Street analysts forecast ATGE stock price to rise over the next 12 months. According to Wall Street analysts, the average 1-year price target for ATGE is 138.33 USD with a low forecast of 135.00 USD and a high forecast of 140.00 USD. However, analyst price targets are subjective and often lag stock prices, so investors should focus on the objective reasons behind analyst rating changes, which better reflect the company's fundamentals.

3 Buy

0 Hold

0 Sell

Strong Buy

20.16% Upside

Current: 115.120

Low

135.00

Averages

138.33

High

140.00

20.16% Upside

Current: 115.120

Low

135.00

Averages

138.33

High

140.00

BMO Capital

Outperform

maintain

$115 -> $132

2025-05-12

Reason

BMO Capital

Price Target

$115 -> $132

2025-05-12

maintain

Outperform

Reason

BMO Capital raised the firm's price target on Adtalem Global Education to $132 from $115 and keeps an Outperform rating on the shares. The company Q3 results beat expectations amid strong enrollment growth and margin expansion and despite continued growth investments, the analyst tells investors in a research note.

Barrington

Outperform

maintain

$120 -> $140

2025-05-09

Reason

Barrington

Price Target

$120 -> $140

2025-05-09

maintain

Outperform

Reason

Barrington raised the firm's price target on Adtalem Global Education to $140 from $120 and keeps an Outperform rating on the shares. The company's fiscal Q3 significantly topped expectations and its full-year guidance was raised, the analyst tells investors in a research note. The firm expects demand for healthcare professionals will continue to outpace supply for the foreseeable future.

Jefferies

Jack Slevin

Strong Buy

Initiates

$135

2025-04-23

Reason

Jefferies

Jack Slevin

Price Target

$135

2025-04-23

Initiates

Strong Buy

Reason

Barrington Research

Alexander Paris

Buy

Maintains

$120

2025-04-15

Reason

Barrington Research

Alexander Paris

Price Target

$120

2025-04-15

Maintains

Buy

Reason

BMO Capital

Jeffrey Silber

Buy

Maintains

$108 → $115

2025-02-03

Reason

BMO Capital

Jeffrey Silber

Price Target

$108 → $115

2025-02-03

Maintains

Buy

Reason

Barrington Research

Alexander Paris

Buy

Maintains

$115 → $120

2025-01-31

Reason

Barrington Research

Alexander Paris

Price Target

$115 → $120

2025-01-31

Maintains

Buy

Reason

Barrington raised the firm's price target on Adtalem Global Education to $120 from $115 and keeps an Outperform rating on the shares following the fiscal Q2 beat. The firm expects demand for healthcare professionals, which represents 90% of Adtalem's total enrollment, will continue to outpace supply for the foreseeable future.

See All Ratings

Valuation Metrics

The current forward P/E ratio for Adtalem Global Education Inc (ATGE.N) is 15.98, compared to its 5-year average forward P/E of 10.89. For a more detailed relative valuation and DCF analysis to assess Adtalem Global Education Inc 's fair value, click here.

Forward PE

The forward P/E ratio is a valuation metric that divides a company's current stock price by its estimated future earnings per share over the next 12 months.

Overvalued

5Y Average PE

10.89

Current PE

15.98

Overvalued PE

13.52

Undervalued PE

8.26

Forward EV/EBITDA

The forward EV/EBITDA ratio is a valuation metric that divides a company's enterprise value (EV) by its estimated future earnings before interest, taxes, depreciation, and amortization (EBITDA) over the next 12 months.

Overvalued

5Y Average EV/EBITDA

7.55

Current EV/EBITDA

9.80

Overvalued EV/EBITDA

9.00

Undervalued EV/EBITDA

6.10

Forward PS

The forward P/S ratio is a valuation metric that divides a company's current stock price by its estimated future sales (or revenue) per share over the next 12 months.

Strongly Overvalued

5Y Average PS

1.40

Current PS

2.23

Overvalued PS

1.78

Undervalued PS

1.02